Apollo Global Management acquiring Covis Pharma — 3 insights

Affiliates of Apollo Global Management will acquire Covis Pharma BV from Cerberus Capital Management, with a planned closing date in the first quarter of 2020.

What you should know:

1. The transaction terms were not disclosed.

2. Covis Pharma CEO Michael Porter said the transaction will allow the company to build out its respiratory continuum of care and establish new therapeutic franchises.

3. Covis currently develops treatments for respiratory, cardiovascular, gastroenterology and central nervous system diseases.

More articles on surgery centers: 
New York endoscopy center shifts ownership
Lowering the CRC screening age to 45: Pros and cons
Smart Medical launches new colonoscope in European market — 3 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers